Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A de Belder

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
Heart (British Cardiac Society)|February 2, 2006
Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromesK Vijayalakshmi, V J Whittaker, B Kunadian, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 1, 2002
A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary interventionAndrew G C Sutton, Victoria J Ashton, Philip G Campbell, et al.
The Journal of Invasive Cardiology|August 23, 2007
Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients: observations from a randomized trial to explore its mode of actionKunadian Vijayalakshmi, Babu Kunadian, Victoria J Whittaker, et al.
Mayo Clinic Proceedings|March 14, 2021
Place and Underlying Cause of Death During the COVID-19 Pandemic: Retrospective Cohort Study of 3.5 Million Deaths in England and Wales, 2014 to 2020Jianhua Wu, Marion Mafham, Mamas A Mamas, et al.
Heart (British Cardiac Society)|January 14, 2015
Impact of renal function on survival after transcatheter aortic valve implantation (TAVI): an analysis of the UK TAVI registryCharles J Ferro, Colin D Chue, Mark A de Belder, et al.
European Heart Journal|December 20, 2015
Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United KingdomAlex Sirker, Mamas Mamas, Derek Robinson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 1997
Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosisA S Brown, Y Hong, A de Belder, et al.
QJM : Monthly Journal of the Association of Physicians|June 12, 2012
Oxygen use for chest pain in coronary care units across the UKD P Ripley, S J Riley, J S Shome, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 23, 2018
Antiplatelet drug selection in PCI to vein grafts in patients with acute coronary syndrome and adverse clinical outcomes: Insights from the British Cardiovascular Intervention Society databaseAlex Sirker, Chun Shing Kwok, Evangelos Kontopantelis, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 31, 2020
Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemicJianhua Wu, Mamas Mamas, Muhammad Rashid, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
Heart (British Cardiac Society)|February 2, 2006
Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromesK Vijayalakshmi, V J Whittaker, B Kunadian, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 1, 2002
A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary interventionAndrew G C Sutton, Victoria J Ashton, Philip G Campbell, et al.
The Journal of Invasive Cardiology|August 23, 2007
Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients: observations from a randomized trial to explore its mode of actionKunadian Vijayalakshmi, Babu Kunadian, Victoria J Whittaker, et al.
Mayo Clinic Proceedings|March 14, 2021
Place and Underlying Cause of Death During the COVID-19 Pandemic: Retrospective Cohort Study of 3.5 Million Deaths in England and Wales, 2014 to 2020Jianhua Wu, Marion Mafham, Mamas A Mamas, et al.
Heart (British Cardiac Society)|January 14, 2015
Impact of renal function on survival after transcatheter aortic valve implantation (TAVI): an analysis of the UK TAVI registryCharles J Ferro, Colin D Chue, Mark A de Belder, et al.
European Heart Journal|December 20, 2015
Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United KingdomAlex Sirker, Mamas Mamas, Derek Robinson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 1997
Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosisA S Brown, Y Hong, A de Belder, et al.
QJM : Monthly Journal of the Association of Physicians|June 12, 2012
Oxygen use for chest pain in coronary care units across the UKD P Ripley, S J Riley, J S Shome, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 23, 2018
Antiplatelet drug selection in PCI to vein grafts in patients with acute coronary syndrome and adverse clinical outcomes: Insights from the British Cardiovascular Intervention Society databaseAlex Sirker, Chun Shing Kwok, Evangelos Kontopantelis, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 31, 2020
Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemicJianhua Wu, Mamas Mamas, Muhammad Rashid, et al.
Pageof 18